Results 261 to 270 of about 2,712,287 (341)

A Randomized, Double-Blind, Controlled Trial Protocol for Therapeutic Neuroscience Education in Chronic Migraine Patients: A Clinical-Neurophysiological Combined Study Design. [PDF]

Methods Protoc
Castaldo M, Atzori T, Comanducci A, Querzola G, Derchi CC, Lovattini D, Manzoni C, Lovati C, Baglio F, Tiberio P, De Sanctis R, Sarasso S, Viganò A.   +12 more
europepmc   +1 more source

Slippery Knowledge: Ignorance, Ecologies, and Environment in Endometriosis Framing

Medical Anthropology Quarterly, EarlyView.
Abstract Despite a growing body of literature linking environmental toxins and endometriosis, environmental issues make only occasional appearances in public, patient, and specialist conversations about endometriosis. These conversations may hover at the edges of public discourse, but do not gain traction.
Andrea Ford
wiley   +1 more source

Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study. [PDF]

Medicina (Kaunas)
Nebrisi EE, Ruwayya ZSA, Alzayori DI, Alzayori RI, Chandran SB, Elshafei M.   +5 more
europepmc   +1 more source

Evidence‐based review and frontiers of migraine therapy

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Cyclic vomiting syndrome (CVS) is identified as one of the “episodic syndromes that may be associated with migraine,” along with benign paroxysmal torticollis, benign paroxysmal vertigo, and abdominal migraine. It has been proposed that CVS and migraine may share pathophysiologic mechanisms of hypothalamic activation and altered ...
Kaitlin A. Greene, Amy A. Gelfand, Larry Charleston IV   +2 more
wiley   +1 more source

Exploring the potential of Fargesin from Chrysanthemum indicum for chronic migraine: in-silico and pharmacokinetic study. [PDF]

Future Sci OA
Rushendran R, Chitra V.
europepmc   +1 more source

Acute care of cyclic vomiting syndrome and cannabinoid hyperemesis syndrome in the home and emergency department

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Abstract Background Cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS) are both characterized by episodic, acute transitions from asymptomatic states to highly symptomatic states of nausea, repetitive vomiting, and often severe abdominal pain.
David J. Levinthal, Blynda Killian, Robert M. Issenman   +2 more
wiley   +1 more source

Treatment principles in adults and development of patient‐reported outcomes in cyclic vomiting syndrome

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
Roadmap to Patient‐Focused Outcome Measurement in Clinical Trials. Source: US FDA, “Patient‐Focused Drug Development: Selecting, Developing, or Modifying Fit‐for‐Purpose Clinical Outcome Assessments”, Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholder.
Yaozhu J. Chen, Milan Patel, Thangam Venkatesan   +2 more
wiley   +1 more source

Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review. [PDF]

Pain Ther
Blumenfeld AM, Mechtler L, Cook L, Rhyne C, Jenkins B, Hughes O, Dabruzzo B, Manack Adams A, Diamond M.   +8 more
europepmc   +1 more source

Future Applications of Central Neuromodulation and Neurophysiological Testing in Cyclic Vomiting Syndrome

Neurogastroenterology &Motility, Volume 37, Issue 3, March 2025.
ABSTRACT Background Cyclic vomiting syndrome (CVS) is defined by its episodic patterning. Furthermore, CVS is associated with other episodic disorders such as migraine and epilepsy. Indeed, many of the medications that are known to be useful for prophylaxis and abortive therapy in CVS are also effective in preventing and aborting migraines and seizures.
David J. Levinthal, Braden Kuo
wiley   +1 more source

Neurophysiological Effects of Withdrawal from Acute Overused Medications in Chronic Migraine with Medication-Overuse Headache. [PDF]

J Clin Med
Sebastianelli G, Casillo F, Abagnale C, Di Renzo A, Ziccardi L, Parisi V, Di Lorenzo C, Serrao M, Coppola G.   +8 more
europepmc   +1 more source